The Rise Fund, TPG’s impact investment vehicle, has led a $210 million Series D round of funding for Meishubao, a China-based online art education platform.
Other investors include Fortune Capital, Winsdom Capital, SAIF Partners, Bojia Capital, and Chuangzhi Capital. Six months ago, the company secured $40 million in a Series C extension led by Tencent Holdings...
New Frontier Japan Investment (NFJI), a lower middle-market Japanese private equity firm, is looking to raise JPY10 billion ($94.4 million) for its second fund.
From fraudulent drawdown notices to ransomware, private equity firms and their portfolio companies are increasingly vulnerable to cyber-attacks. Training and vigilance are paramount
WuXi Diagnostics, a joint venture China diagnostics business set up by Hong Kong-listed pharmaceutical outsourcing giant WuXi AppTec and US-based Mayo Clinic has completed a $150 million Series B funding round.
Affirma Capital came into being 18 months ago as Standard Chartered’s private equity team spun out with most of the remaining balance sheet assets. COO Ivo Philipps explains the middle and back office transition